RxDoctor Payments Data

Selene Parekh, MD

Orthopaedic Surgery · Bensalem, PANPI 1588601488

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $3,447,010 of the $4,483,670 with a category attached, or 76.9%. 51 manufacturers reported payments, led by Arthrex at 52.3% of the total. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,483,670in general payments, 2019–2025

Across 589 payments — averaging $7612.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2.3M
  • Smith+Nephew$497K
  • Medshape, Inc.$388K
  • Integra Lifesciences Corporation$318K
  • Acumed LLC$203K
  • Paragon 28, Inc.$159K
  • plus $573K from 45 others
$37,886in research payments, 2019–2025

Across 17 payments — averaging $2228.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$24K
  • Stryker$14K
$357,561in ownership & investment interests, 2019–2025

Across 26 payments — averaging $13,752 each. An ownership or investment interest held by the physician or an immediate family member.

  • Tyber Medical, LLC$250K
  • Zimmer Biomet$53K
  • Alafair Biosciences, Inc.$30K
  • Ossio LTD$25K
  • Extremity Medical$100
  • Embody, Inc.$0

What the payments were for

  • Royalty or licence$3,447,01077%
  • Consulting fees$344,0368%
  • Speaking & faculty fees$135,1773%
  • Grants$7,5000%
  • Travel & lodging$49,4401%
  • Food & beverage$9,0730%
  • Gifts$2,5060%
  • Charitable contribution$7,5000%
  • Ownership interest$14,9950%
  • Other$466,43210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,483,670 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$153,024
Medicare patients
251
Services billed
1,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl72$254
Gabapentin100$248
Meloxicam159$214
Promethazine Hcl39$175
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$115

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bensalem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →